Mergers & AcquisitionsPublic Securities Practice

SA&M Advises HemaCare Corporation in the Sale of Coral Blood Services to the New York Blood Center

By October 11, 2013 No Comments

Los Angeles, October 11, 2013. Stubbs Alderton & Markiles, LLP announced that it advised client HemaCare Corporation in the sale of its Coral Blood Services subsidiary to the New York Blood Center (“NYBC”). Financial terms of the transaction were not disclosed.  Coral’s 24 employees have been offered equivalent positions at NYBC.

In addition, NYBC and HemaCare have signed an agreement granting HemaCare access to NYBC’s 22 metro New York area collection centers.  This allows HemaCare to further support the skilled, standardized apheresis collection services required for cell therapy and immunotherapy clinical trials of HemaCare’s rapidly growing list of BioResearch Products and Services customers.

SAM Partner John McIlvery, and attorney Jonathan Friedman  advised HemaCare Corporation in this transaction.

To read the full press release, click here.